Magali IRLA, PhD, at the CIML has been nominated as a laureate of the National Academy of Medicine for the 2019 Prize of the Société des Eaux Minérales d'Evian-les-Bains which aims to encourage scientific research. This prize is awarded for her work entitled: "At the heart of the establishment of immune tolerance: regulation of…
Michel PIERRES, a world-renowned physician and immunologist, died on June 14, 2019
One of the first team leaders of the CIML, Michel Pierres was director of the centre from 1991 to 1995. His work on the characterization of molecules associated with T lymphocyte activation using monoclonal antibodies helped to position the…
Le rapport d'activité Inserm 2018 vient de paraitre
Parmi les avancées scientifiques de l'année 2018, en page 9, un article sur les travaux de l'équipe d'Eric VIVIER du Centre d'Immunologie de Marseille-Luminy : Un nouvel anticorps efficace contre le cancer de la tête et du cou...…
A study by the Bernard Malissen (CIML CNRS, Inserm, AMU Marseille), M. Gstaiger (IMSB) and R. Aebersold (IMSB) groups which appeared in Cell Reports, identifies using proteomics and mouse models molecular mechanisms that might account for some of the failures observed during immunotherapy...…
Le Pr Eric Vivier, DVM, PhD, vient d’être élu Membre de l’Organisation Européenne de Biologie Moléculaire (EMBO). Professeur en immunologie, Hôpital de la Timone, Assistance-Publique des Hôpitaux de Marseille, Centre d’Immunologie de Marseille Luminy, Aix Marseille Université - INSERM - CNRS, Innate Pharma, Marseille Immunopôle…
DÉCRYPTER DEUX LYMPHOMES B PARMI LES PLUS FRÉQUENTS POUR MIEUX LES TRAITER : UN PROJET INÉDIT ET AMBITIEUX DÉMARRE À MARSEILLE.
Le Centre d’Immunologie de Marseille-Luminy et l’institut Carnot CALYM lancent le projet collaboratif ATLAS avec le soutien institutionnel du laboratoire Celgene, le 25 avril…
The CIML organizes several Scientific and Public events in May 2019..., More information
…
Webcast of the INSERM 2018 awards ceremony. Pierre GOLSTEIN, DR Inserm at CIML, received the Special Prize for being the first to identify the CTLA-4 protein, now targeted in cancer immunotherapy strategies. Watch the video, including Pierre Golstein's speech between the 32nd and 36th minutes.…
